天然保健食品之專利戰略 是由出版商Business Insights在2011年09月所出版的。
這份英文市場調查報告書包含Pages: 101 價格從美金2875起跳。
隨功能化食品產業崛起，有效之專利策略越顯重要。本報告為，分析營養保健食品專利範圍及種類別，並匯整獲得專利之新創新技術探討、未來商業機會、使用天然藥劑或開發半合成新藥領域之商業機會等，以下列摘要形式闡述。
第1章 實施概要
第2章 關於作者
第3章 專利策略
- 概要
- 本報告目的
- 專利為何
- 治療效果專利要件
- 專利之法規架構
- 專利費用
- 歐洲專利局(EPO)專利費用
- 全球智慧財產機構(WIPO)專利費用
- 美國專利和商標局(USPTO)費用
- 天然營養補給食品及NCE專利範圍種類別
- 強調天然營養補給食品之健康效果多為民間口語相傳
- 天然營養補給食品及藥物製成之專利策略
- 天然營養補給食品及藥物之處方專利策略
- 延長專利期間
- NCE專利及天然營養補給食品專利之不同
- 未來專利策略
第4章 法規情形
- 概要
- EU法規情形
- 美國法規情形及專利代表訴訟
- 日本天然營養補給食品之法規訴訟
- 未來
第5章 石榴提取物專利策略
- 概要
- POM Wonderful LLC
- POM Wonderful公司之專利策略
- 由FDA/FTC之行政警告資料
- PoliNat公司
- Verdure Science公司
- Amazentis SA公司
第6章 未來展望
- 概要
- 專利活動活絡
- 授權策略
- 新興市場
- 新技術
- 相關醫療藥物開發可行性
Description
INTRODUCTION
The rise of the functional food industry is increasing the significance of effective patenting strategies. This report assesses the range and types of patenting in the nutraceutical industry. It also examines new innovations in patenting and identifies future opportunities, such as the area of using natural drugs for semi-synthetic approaches to drug development.
FEATURES AND BENEFITS
- Gain an understanding of the legal patent frameworks to enable the evaluation of the strengths and weaknesses of the various patenting strategies.
- Compare and contrast the patenting framework for nutraceuticals and pharmaceuticals.
- Examine recent trends in the patenting of natural nutraceuticals.
- Analyze the range of products and patenting in the area of pomegranate nutraceuticals and understand the competitive nature of the area.
- Identify which products have gained EFSA positive opinions and consider the implications of tightened regulations on patenting strategies.
HIGHLIGHTS
The patent landscape for nutraceuticals is not as strong as for new drugs (new chemical entities), because many research institutions and companies have patented, or are researching various aspects of, the same natural nutraceutical, which makes it difficult to obtain strong patent claims.
Following the introduction of new regulations in Europe and the tightening of the FDA's stance, there has been an increase in the specificity of claims within patents, i.e. claiming active principles more precisely in order to characterize the extract and add precision to the role of the active principle in the health claim.
Reflective of the nutraceutical industry's focus on formulation innovation, formulation patenting is growing. The development of delivery systems to improve the bioavailability of nutraceuticals is a key area of focus for the industry and as such, new technologies that offer such potential will be integral to a company's patenting strategy.
YOUR KEY QUESTIONS ANSWERED
- What are the patent strategies of the successful innovative nutraceutical companies?
- What impact has the changing regulatory environment had on recent patenting activity?
- Which nutraceuticals have received EFSA positive opinions?
- Who are the key players in patenting and developing pomegranate-containing natural nutraceutical products?
- How do companies use licensing to complement their intellectual property portfolios?
Table of Contents
Executive Summary
- Patenting strategies
- Regulatory and legal landscape
- Pomegranate extracts patent strategies
- Conclusions
About the author
Patenting strategies
- Summary
- What is this report about?
- Introduction
- What is a patent?
- Requirement for a therapeutic patent
- Legal patent frameworks
- United States
- European
- Patent Cooperation Treaty
- Patenting costs
- EPO patenting fees
- WIPO patenting fees
- USPTO fees
- Types of patent claims for natural nutraceuticals versus NCEs
- Health claims of natural nutraceuticals often arise from folklore
- Process patenting strategies for natural nutraceuticals versus drugs
- Formulation patenting strategies for nutraceutical versus drugs
- Patent term extensions
- Differences in NCE and natural nutraceutical patenting
- New chemical entities
- Natural nutraceuticals
- Future patenting strategies
Regulatory and legal landscape
- Summary
- Introduction
- EU regulatory landscape
- Article 13 claims
- Article 13(5) claims
- Article 14 claims
- US regulatory landscape and class actions
- Japanese nutraceutical regulatory landscape
- The future
Pomegranate extracts patenting strategies
- Summary
- Introduction
- POM Wonderful LLC
- POM Wonderful's patenting strategy
- FDA/FTC Warning Letters
- PoliNat (Polifenoles Naturales S. L.)
- PoliNat's patenting strategy
- Verdure Sciences
- Verdure Sciences' patenting strategy
- Amazentis SA
- Health Love Co Ltd
- Health-Love patent strategy
- Probelte Pharma SA
- Probelte Pharma's patenting strategy
- Sigma-Tau Industrie Farmaceutische Riunite S. P. A.
- Sigma-tau Industrie Farmaceutiche Riunite pomegranate patenting
- Johnson & Johnson Consumer Companies, Inc.
- 4Life
- Rimonest Ltd and Punisyn Pharmaceuticals
- Rimonest's patent portfolio
- Inventor - Salvatore Tirrito patenting
Future outlook
- Summary
- Introduction
- Increased patent activity
- Licensing strategies
- Emerging markets
- New technologies
- Delivery systems
- Nutrigenomics
- Potential for associated pharmaceutical development
Appendix
- Scope
- Methodology
- Glossary/Abbreviations
- Bibliography/References
- Regulatory and legal landscape chapter
- Pomegranate extracts patenting strategies chapter
